Covidien sees healthy device sales growth in 2013; South Koreans develop laser-based needle device;

 @FierceMedDev: Tandem Diabetes Care raked in $36M to further market its super-slim insulin pump. News | Follow @FierceMedDev

 @MarkHFierce: Covidien expects medical device sales to grow 4% to 7% in FY 2013. Release | Follow @MarkHFierce

 @DamianFierce: U.K. engineers have come up with an ultrasound scanner that can made for about $65, targeting developing countries. More | Follow @DamianFierce

> Covidien ($COV) told investors this week that it is on track spinning off its pharmaceuticals business by mid-2013, and that medical device net sales should grow 4% to 7% in fiscal 2013. Release

> Scientists at Seoul National University in South Korea have developed a laser-based needle device that blasts microscopic jets of drugs into the skin, pain free. Release

> Canadian medical device startup Innovative Trauma Care is opening its U.S. headquarters in Texas to drive commercial sales of a clamp that stops bleeding from open wounds within seconds. Story

> The Sorin Group recently gained Chinese FDA approval of its Reply and Esprit families of pacemakers. Release

> Amedica is expanding biomaterial claims for its 510(k)-cleared spinal and reconstructive device implants. Release

> Diagnostics firm Qiagen ($QGEN) is expanding into China, teaming up with Lepu Medical to provide its ESEQuant lateral flow system to test for cardiac biomarkers. More

> The University of California, San Diego's Jacobs School of Engineering has launched a master's program designed to train students for careers in the medical device industry. News

Biotech News

 @FierceBiotech: Neural stem cells partially restore mobility in paralyzed rats. Story | Follow @FierceBiotech

 @RyanMFierce: My conversation with biotech heavy hitter and NEA partner David Mott about investing big in therapeutics startups. Editor's Corner | Follow @RyanMFierce

> Pharma counts just 3 Alzheimer's drug wins in 13 years (101 losses!). Article

> Massachusetts tops in U.S. for growth in biotech research jobs. Story

> Zambon, Italian pharma partner clash over CNS deal. Report

Pharma News

 @FiercePharma: Bayer picks up Teva's animal health biz for $145M. News | Follow @FiercePharma

 @EricPFierce: Health Canada says it will rank drug manufacturing issues by risk of product and by 3 levels of concern. FiercePharmaManufacturing article | Follow @EricPFierce

> Mylan may make another acquisition in India. More

> Boehringer Ingelheim lets Facebook game loose. Story

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.